Beneficial effects of thromboxane receptor antagonists in acute cardiovascular crises

A M Lefer¹

Affiliations

Review

A M Lefer. Prog Clin Biol Res. 1987.

. 1987:242:221-8.

A M Lefer¹

¹ Department of Physiology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107.

No abstract available

Similar articles

Pharmacology of thromboxane A2 receptor antagonists.
Halushka PV. Halushka PV. Z Kardiol. 1989;78 Suppl 3:42-7. Z Kardiol. 1989. PMID: 2530712 Review.
Role of thromboxane receptor antagonists in cardiovascular disease.
Smith EF 3rd. Smith EF 3rd. Prog Clin Biol Res. 1989;301:29-38. Prog Clin Biol Res. 1989. PMID: 2529549 Review.
Beneficial actions of the thromboxane receptor antagonist, AH-23,848, in acute myocardial ischemia.
Brezinski ME, Osborne JA, Yanagisawa A, Lefer AM. Brezinski ME, et al. Methods Find Exp Clin Pharmacol. 1987 Nov;9(11):703-9. Methods Find Exp Clin Pharmacol. 1987. PMID: 2966270
Thromboxane synthetase inhibitors, thromboxane receptor antagonists, and aspirin in cardiovascular disease.
Dorn GW 2nd, Halushka PV. Dorn GW 2nd, et al. Ration Drug Ther. 1985 Jul;19(7):1-7. Ration Drug Ther. 1985. PMID: 2997839 Clinical Trial. No abstract available.
Molecular and functional evidence for the distinct nature of F2-isoprostane receptors from those of thromboxane A2.
Yura T, Fukunaga M, Grygorczyk R, Makita N, Takahashi K, Badr KF. Yura T, et al. Adv Prostaglandin Thromboxane Leukot Res. 1995;23:237-9. Adv Prostaglandin Thromboxane Leukot Res. 1995. PMID: 7732843 No abstract available.